Daily Morning Note – 27 Oct 2020


US stocks posted their worst session in weeks on Monday, driven downwards by fading hopes for US stimulus, mounting worries over the coronavirus and jitters over the November 3 elections. The decline came as data compiled by Johns Hopkins University showed daily coronavirus cases in the U.S. have risen by an average of 68,767 over the past seven days, a record.

The major indexes recovered from the low points of the day, but the Dow Jones Industrial Average still dropped 2.3 per cent to end at 27,685.38, a loss of 650 points. The broad-based S&P 500 fell 1.9 per cent to close the session at 3,400.97, while the tech-rich Nasdaq Composite Index shed 1.6 per cent to 11,358.94.

Meanwhile, fresh Covid-19-induced restrictions in Italy and Spain to curb a resurgence in cases weighed on the rest of Europe, with the pan-European Stoxx 600 index closing at a one-month low, down 1.8 per cent.


Mainboard-listed SIA Engineering Company , has entered into two agreements with Cebu Air: one was to buy out the latter’s interest in SIA Engineering Philippines Corporation (SIAEP), and the other to sell its stake in Aviation Partnership (Philippines) Corp (APP) to the budget airline. In statements to the bourse operator, the engineering unit of Singapore Airlines (SIA) announced on Monday that it will pay US$7.74 million for Cebu Air’s 35 per cent shareholding in SIAEP, making it SIA Engineering’s wholly-owned subsidiary.

The Monetary Authority of Singapore (MAS) issued a Notice of Intention (NOI) to remove the manager of Eagle Hospitality Reit (EH-Reit) ,and to appoint a new manager. Since it was licensed in May 2019, EH-Reit Management has committed multiple breaches of the SFA, including breaches of the minimum base capital and financial resources requirements, said MAS.

UOB said it has seen a twofold increase in the number of construction firms obtaining loans under value chain financing (VCF) in the first six months of the year, as compared with the end of 2019. The growth was driven by the increase in sub-contractors and suppliers obtaining loans under VCF, as part of tie-ups between their main contractors or project owners and the bank to help ease financing challenges brought about by Covid-19, UOB said in a statement.

Ascendas Reit’s,manager announced in a business update that although a challenging economic outlook could affect its future performance, its well-diversified portfolio and tenant base should help mitigate potential problems. For its third quarter ended Sept 30, 2020, its portfolio occupancy had edged up to 91.9 per cent quarter on quarter, mainly attributable to a higher occupancy rate of 88.8 per cent in the Singapore portfolio.

Jack Ma’s Ant Group is set to raise about US$34.5 billion through initial public offerings in Shanghai and Hong Kong, a blockbuster listing that will rank as the biggest IPO ever and make it one of the most valuable finance firms on the planet. The fintech giant will have a market value of US$315 billion even before exercising its greenshoe option, based on filings Monday. That’s about the same valuation as JPMorgan and four times larger than Goldman Sachs Group Inc.

Aero-engine maker Rolls-Royce will ask shareholders on Tuesday for 2 billion pounds (S$3.54 billion) in a make-or-break attempt to survive the Covid-19 pandemic, which has stopped planes flying and hammered its finances. Investors can buy 10 new shares for every three they own at 32 pence (S$0.57) each, a 41 per cent discount to the theoretical ex-rights price.

Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, PSR


Medtecs International Corp Ltd

Recommended Action: Technical BUY

Analyst: Chua Wei Ren

Medtecs International Corp Ltd (SGX: 546) bullish upside has played out according to plan based on our report on 23rd September 2020. Based on the technical, the upside will continue despite the rejection of resistance zone 1 on 14th October 2020.

Singapore Exchange Ltd

Recommended Action: Technical BUY

Analyst: Chua Wei Ren

Singapore Exchange Ltd (SGX: S68) bullish upside has been cemented since our report dated 16th September 2020 has stated that once prices clear above the then 200-day moving average, the bullish outlook is set. Based on the technical, the upside is likely to continue.

Hi-P International Ltd

Analyst: Chua Wei Ren

Recommended Action: Technical BUY

Hi-P International Ltd (SGX: H17) is set to continue another round of upside after a long bout of corrective expanded flat. Based on the technical, the stock is set to move on the upside to test the resistance zone 1 again.

>> Read more Technical reports


Webinar Of The Week

Market Outlook: (PSR) US Election (Healthcare), Bond Model Portfolio Review, Nanofilm Tech IPO & more

Date: 26 October 2020

For more on Market Outlook

Updates summarised in 3 minutes

Phillip Research in 3 minutes: #26 – iX Biopharma Ltd; Initiation

For more videos on Phillip in 3 Mins

Read the research report(s), available through the link(s) above, for complete information including important disclosures Important Information

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Confidentiality Note
This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.


Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com